RE:RE:RE:RE:Short Positions Just keep on IncreasingMUGMODs wrote: Case in point ... I have said time and time again ... that just like Paladin, which fluctuated between $5-$7 a share for a few years before the rocket started its lift-off. That is also how I see it with Knight but the wait could be extended (because we are starting from small drug development) and the lift-off could be packed with a mightier punch. Just my thoughts.
Yawn! You've been saying this for over a year already. This turd is being outperformed by Endo and Valeant, the 2 companies who's carcas the CEO wanted to feed on. Both are up 300% while this turd is down 25%. Many 'experts' on this forum said these were 'bankrupt' companies. lol....Are we still waiting for Endo to come begging? So embarrasing!